MicroStockHub Per LSEG, only 29 companies have reported their Q1 ’24 earnings so far, and the big banks that reported on Friday morning April 12th, won’t be in the numbers so to speak until Monday, April 15th or Tuesday, April 16th. Another 41 companies are expected to report this week. The point being to all…
Get ahead of the market by subscribing to Seeking Alpha’s Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentations. Economic reports in the week ahead include updates on…
Michael Warren/E+ via Getty Images Introduction and thesis Johnson Outdoors (NASDAQ:JOUT) is a leading global manufacturer and marketer of outdoor recreational products. Johnson Outdoors operates through multiple brands, offering a diverse range of outdoor gear and equipment for various recreational activities such as fishing, camping, diving, and water sports. JOUT Whilst our rating of JOUT…
Mario Tama/Getty Images News Thesis Johnson & Johnson (NYSE:JNJ) is a multinational corporation that operates in the healthcare and pharmaceutical sectors. Founded in 1886, the company is headquartered in New Brunswick, New Jersey, USA. JNJ is one of the largest and most diversified healthcare companies globally. Having experienced a dip in terms of its profitability…
Mario Tama/Getty Images News Quick Background If you’re like me at all, you enjoy being a stock picking voyeur. What I mean is that it’s both interesting and fun to listen to someone explain their stock picks. This is especially enjoyable as a fly on the wall, where you don’t necessarily have to interact or…
FG Trade Johnson & Johnson (NYSE:JNJ) is an American corporation focused on the creation and manufacturing of medical devices, vaccines, and medicines designed to address a range of prevalent illnesses, such as cancer, cardiovascular diseases, and neurological disorders. Thesis Over the past two weeks, Johnson & Johnson’s share price has continued to trend upward despite…
ricochet64 Investment Thesis Johnson Controls International (NYSE:JCI) is a building automation multinational based in the US. JCI traces its origin to the first-ever electric thermostat and has since grown to operate in over 150 countries with a wide breadth of service and product offerings. JCI is a leader in green buildings, pushing toward net zero…
Get ahead of the market by subscribing to Seeking Alpha’s Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentations. Stocks to Watch subscribers can also tune in on…
takasuu/iStock via Getty Images Thesis We keep reminding our readers – and ourselves – that in investing, avoiding losses is more important than achieving gains (even though the latter always FEELs better). The reason is a simple math fact – because compounding is mathematically asymmetric. A 10% loss requires more than a 10% gain to…
KucherAV/iStock via Getty Images Johnson & Johnson (NYSE:JNJ) is one of the largest companies in the healthcare sector, headquartered in New Brunswick. Investment thesis Since our last article was published in early August 2023, its share price has been under downward pressure. However, in October, it reached a price level at which we believe the…
Moussa81 This article was co-produced with Kody Kester of Kody’s Dividends. ——————————————————————————— Achieving your financial goals doesn’t require a genius IQ, but you need the emotional stability to stand by said strategy in tough times. Johnson & Johnson (NYSE:JNJ) is a legendary healthcare company with a renewed focus on its pharmaceutical and medtech segments, making…
Jag_cz/iStock via Getty Images Introduction I first published on Johnson Outdoors Inc. (NASDAQ:JOUT) almost a year ago, arriving at a Buy rating with the stock then trading at around $55 per share. By early January 2023, JOUT’s share price had increased by ~23% from my Buy recommendation level, and after reviewing the company’s 4Q22 result,…
yuelan I last updated investors in Johnson & Johnson, or J&J (NYSE:JNJ), in early April, urging them to capitalize on its capitulation to add more shares. That thesis has worked out well, as JNJ dip buyers held its March lows ($150 level), lifting buying sentiments. Following its remarkable surge into its early August highs ($176…
Pgiam/iStock via Getty Images Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is developing JNJ-2113 (PN-235), an oral IL-23 drug targeting psoriasis, however partner Johnson & Johnson (JNJ) says that until the oral drug can show non-inferior efficacy to J&J’s own injectable anti-IL-23 drug Tremfya, there is no point in developing it further. In April, Protagonist went up considerably…
Sundry Photography Investment Thesis Johnson & Johnson (NYSE:JNJ) is a renowned worldwide healthcare conglomerate celebrated for its extensive array of pharmaceuticals, medical devices, and consumer healthcare merchandise. In 2022, Johnson & Johnson was acknowledged as the most valuable brand in the pharmaceutical sector, with an impressive brand value of $13.4 billion. Most Valuable Pharma Brands…
Johnson & Johnson (NYSE:JNJ) 2023 Wells Fargo Securities Healthcare Conference September 7, 2023 10:15 AM ET Company Participants Michael Bodner – Global Head of Heart Recovery Andrew Greenfield – Worldwide President Charles Simonton – Chief Medical Officer and Global Vice President, Clinical and Medical Affairs Ashley McEvoy – Executive Vice President and Worldwide Chairman, Medical…
Johnson & Johnson (NYSE:JNJ) UBS MedTech, Tools and Genomics Summit Conference Call August 15, 2023 2:00 PM ET Company Participants Celine Martin – Group Chairman Jasmina Brooks – President, Biosense Webster Anthony Hong – Vice President, Preclinical and Clinical Research and Medical Affairs Conference Call Participants Danielle Antalffy – UBS Danielle Antalffy Alright. Good morning,…